	Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia. Am J Hematol Kadia TM, Bataller A, Bazinet A, Borthakur G, Daver N, Short NJ, DiNardo C, Jabbour E, Rausch CR, Issa GC, Pemmaraju N, Ohanian M, Maiti A, Montalban-Bravo G, Sasaki K, Bouligny IM, Yilmaz M, Haddad FG, Masarova L, Chien K, Alvarado Y, Jain N, Popat U, Shpall E, Loghavi S, Qiao W, Wang X, Garcia-Manero G, Ravandi F, Kantarjian HM. PMID: 42035228 [PubMed - as supplied by publisher]
	Immunotherapy in acute myeloid leukemia: The antibodies, TriKEs, and CARs on the arduous road to cure. Blood Rev Adhikari B, Litzow MR, Dias AL. PMID: 42034501 [PubMed - as supplied by publisher]
	Impact of the diagnosis-to-treatment interval on the survival of patients with CD5-positive diffuse large B-cell lymphoma. Ann Hematol Nato Y, Miyazaki K, Maruyama D, Takahashi H, Sunami K, Negoro E, Murakami S, Okada T, Takayama N, Miyazawa Y, Choi I, Momose S, Kaneda Y, Yoshida M, Tomita N, Murayama T, Nishikori M, Hiraga J, Toyama K, Takahashi N, Masunari T, Takizawa J, Tawara I, Asano N, Ohshima K, Izutsu K, Kato K, Suzuki R, Yamaguchi M. PMID: 42033496 [PubMed - in process]
	Targeting the BCR::ABL1 Kinase: Advances Beyond Imatinib in Chronic Myeloid Leukemia. Curr Hematol Malig Rep Naderi Z, Sadras T, Branford S, Shanmuganathan N, Pagani IS. PMID: 42033491 [PubMed - in process]
	Acute myeloid leukemia after myeloproliferative neoplasms: Real-world outcomes in the new treatment era in the United States. Cancer Bewersdorf JP, Wang R, Mendez L, Mina A, Aguirre LE, Stahl M, Zeidan AM, Ma X, Podoltsev NA. PMID: 42033416 [PubMed - indexed for MEDLINE]
	Advances in natural killer cell immunotherapy for hematologic malignancies. Cancer Biol Ther Hu H, Xiong Y, Xia M, Sheng L. PMID: 42033215 [PubMed - indexed for MEDLINE]
	Dietary Compounds Drive Epigenetic Regulation and Modifications in Blood Cancer: A Critical Review. Mol Nutr Food Res Ikhtiar F, Jamal A, Kiran S, Hossain MB. PMID: 42033074 [PubMed - indexed for MEDLINE]
	Blinatumomab and Ponatinib Versus Hyper-CVAD and Ponatinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Propensity Score Analysis. Am J Hematol Sasaki K, Kantarjian H, Rausch CR, Goulart H, Jain N, Huang X, Hachem M, Wierda WG, Kadia TM, Borthakur G, Issa GC, Alvarado Y, Pemmaraju N, Garris R, Ravandi F, Garcia-Manero G, Short NJ, Jabbour E. PMID: 42031676 [PubMed - as supplied by publisher]
	Mecapegfilgrastim for Prophylaxis of Immunochemotherapy-Induced Neutropenia in Patients With Diffuse Large B-Cell Lymphoma: A Multicenter Pilot Trial. Cancer Med Wang J, Li H, Lin Q, Guo Y, Ma H, Xiang B, Yang C, Shen K, Zhang C, Yang K, Ma C, Zhai H, Wei J, Zuo Y, Zhou J, Niu T. PMID: 42030265 [PubMed - indexed for MEDLINE]
	From rumination quagmire to hope's flame: a cross-sectional mediation study of family support and life satisfaction among hematological cancer caregivers. Support Care Cancer Fu S, Xiao X, Ren Z. PMID: 42029747 [PubMed - indexed for MEDLINE]
	Diffuse Infiltrating Perisellar Mass Mimicking Polyneuritis Cranialis. Eur J Neurol Kastner PP, Niederau PL, Pantazis G, Seystahl K. PMID: 42029394 [PubMed - indexed for MEDLINE]
	Association of Proteinuria With Disease Stage and Treatment Response in Patients With Lymphoma: A Prospective Cohort Study. Cureus Kumar N, Atri SK, Chaudhary V, Malik P, Chatterjee K, Arora G, Kumari M. PMID: 42028490 [PubMed]
	Predictors of sensitivity to immune therapies in classic Hodgkin lymphoma. Blood Neoplasia Alibrahim MN, Carbone A, Gloghini A. PMID: 42027746 [PubMed]
	Encouraging response rates and high mobilization success with brentuximab vedotin plus GDP in adult relapsed/refractory classical Hodgkin lymphoma: A real-world study. Leuk Res Rep Namdaro, Batgi H, Kakc, Öztürk OC, , Güzel B, Tayfur K, Ba. PMID: 42027627 [PubMed]
	A real-world multicenter study of first-line zanubrutinib-based therapy for diffuse large B-cell lymphoma. Leuk Lymphoma Hu L, Lu B, Wei X, Wang Y, Xie M, Li J, Feng C, Li G, Qiu X, Zhang J, Guo X, Zhong Z, Li X, Zhang Q, Zhou J. PMID: 42027122 [PubMed - as supplied by publisher]
	ASC4OPT: asciminib treatment optimization study in patients with chronic myeloid leukemia in chronic phase previously treated with two or more tyrosine kinase inhibitors. Leukemia Hochhaus A, le Coutre P, Milojkovic D, Kim DDH, Lim SM, Pavlovsky C, Nguyen T, Nicolini FE, Moiraghi B, Grosicki S, Phu CD, Etienne G, Marco de Lucas F, Ayala Diaz RM, Breccia M, Chuah C, Abi Rached R, Pokhriyal H, Ic A, Schuld P, Pilipovic V, Alisch F, Boquimpani CM. PMID: 42026180 [PubMed - as supplied by publisher]
	Evaluation of incidence and outcomes of transformed nodular lymphocyte predominant Hodgkin Lymphoma in the United States: a population-based cohort study. Blood Cancer J Vaughn JL, Munir M, Cobb A, Rimmalapudi S, Epperla N. PMID: 42026026 [PubMed - in process]
	Pathways-to-Care Analysis of Non-Hodgkin Lymphoma in Ethiopia: A Mixed-Methods Study. JCO Glob Oncol Baissa OT, Abdela F, Tadesse F, Damie A, Sori M, Hailu W, Bizuneh S, Abebe B, Mulu BA, Amir G, Roberman S, Dos-Santos-Silva I, Paltiel O. PMID: 42024844 [PubMed - indexed for MEDLINE]
	Bovine Leukemia Virus Prevalence in Women with Breast Cancer and Premalignant Breast Lesions. Viral Immunol Kürkçü MF, , , Bak. PMID: 42024437 [PubMed - as supplied by publisher]
	The Role of Artificial Intelligence Algorithms in Challenging Diagnostic Cases - Between Potential and Real Clinical Support. Otolaryngol Pol Doligalska-Dolina A, Zió, Wróbel MJ. PMID: 42023639 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 167285

Page 1 of 8365



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy